171 related articles for article (PubMed ID: 28902353)
1. Identification of WISP1 as a novel oncogene in glioblastoma.
Jing D; Zhang Q; Yu H; Zhao Y; Shen L
Int J Oncol; 2017 Oct; 51(4):1261-1270. PubMed ID: 28902353
[TBL] [Abstract][Full Text] [Related]
2. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
[TBL] [Abstract][Full Text] [Related]
3. WNT1-inducible signaling pathway protein 1 (WISP1/CCN4) stimulates melanoma invasion and metastasis by promoting the epithelial-mesenchymal transition.
Deng W; Fernandez A; McLaughlin SL; Klinke DJ
J Biol Chem; 2019 Apr; 294(14):5261-5280. PubMed ID: 30723155
[TBL] [Abstract][Full Text] [Related]
4. High expression of WISP1 in colon cancer is associated with apoptosis, invasion and poor prognosis.
Wu J; Long Z; Cai H; Du C; Liu X; Yu S; Wang Y
Oncotarget; 2016 Aug; 7(31):49834-49847. PubMed ID: 27409174
[TBL] [Abstract][Full Text] [Related]
5. WISP1 aggravates cell metastatic potential by abrogating TGF-
Song D; Wang L; Su K; Wu H; Li J
Exp Biol Med (Maywood); 2021 Jun; 246(11):1244-1252. PubMed ID: 33593111
[TBL] [Abstract][Full Text] [Related]
6. WNT-1 inducible signaling pathway protein-1 enhances growth and tumorigenesis in human breast cancer.
Chiang KC; Yeh CN; Chung LC; Feng TH; Sun CC; Chen MF; Jan YY; Yeh TS; Chen SC; Juang HH
Sci Rep; 2015 Mar; 5():8686. PubMed ID: 25732125
[TBL] [Abstract][Full Text] [Related]
7. WISP1 overexpression promotes proliferation and migration of human vascular smooth muscle cells via AKT signaling pathway.
Lu S; Liu H; Lu L; Wan H; Lin Z; Qian K; Yao X; Chen Q; Liu W; Yan J; Liu Z
Eur J Pharmacol; 2016 Oct; 788():90-97. PubMed ID: 27321870
[TBL] [Abstract][Full Text] [Related]
8. Dual Role of WISP1 in maintaining glioma stem cells and tumor-supportive macrophages in glioblastoma.
Tao W; Chu C; Zhou W; Huang Z; Zhai K; Fang X; Huang Q; Zhang A; Wang X; Yu X; Huang H; Wu Q; Sloan AE; Yu JS; Li X; Stark GR; Rich JN; Bao S
Nat Commun; 2020 Jun; 11(1):3015. PubMed ID: 32541784
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-384 regulates cell proliferation and apoptosis through directly targeting WISP1 in laryngeal cancer.
Wang L; Sun J; Cao H
J Cell Biochem; 2019 Mar; 120(3):3018-3026. PubMed ID: 30548664
[TBL] [Abstract][Full Text] [Related]
10. The tumor cell-secreted matricellular protein WISP1 drives pro-metastatic collagen linearization.
Jia H; Janjanam J; Wu SC; Wang R; Pano G; Celestine M; Martinot O; Breeze-Jones H; Clayton G; Garcin C; Shirinifard A; Zaske AM; Finkelstein D; Labelle M
EMBO J; 2019 Aug; 38(16):e101302. PubMed ID: 31294477
[TBL] [Abstract][Full Text] [Related]
11. Wisp1 mediates Bmp3-stimulated mesenchymal stem cell proliferation.
Cernea M; Tang W; Guan H; Yang K
J Mol Endocrinol; 2016 Jan; 56(1):39-46. PubMed ID: 26489765
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of WISP1 inhibit proliferation and induce apoptosis in ALL Jurkat cells.
Zhang X; Chen X; Liu J; Dong X; Jin Y; Tian Y; Xue Y; Chen L; Chang Y; Liu Y; Wang J
Int J Clin Exp Pathol; 2015; 8(11):15489-96. PubMed ID: 26823919
[TBL] [Abstract][Full Text] [Related]
13. MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression.
Chen W; Xu XK; Li JL; Kong KK; Li H; Chen C; He J; Wang F; Li P; Ge XS; Li FC
Oncotarget; 2017 Apr; 8(14):22783-22799. PubMed ID: 28187000
[TBL] [Abstract][Full Text] [Related]
14. p53 upregulated modulator of apoptosis sensitizes drug-resistant U251 glioblastoma stem cells to temozolomide through enhanced apoptosis.
Miao W; Liu X; Wang H; Fan Y; Lian S; Yang X; Wang X; Guo G; Li Q; Wang S
Mol Med Rep; 2015 Jun; 11(6):4165-73. PubMed ID: 25625235
[TBL] [Abstract][Full Text] [Related]
15. Association of Wnt1-inducible signaling pathway protein-1 with the proliferation, migration and invasion in gastric cancer cells.
Jia S; Qu T; Feng M; Ji K; Li Z; Jiang W; Ji J
Tumour Biol; 2017 Jun; 39(6):1010428317699755. PubMed ID: 28618940
[TBL] [Abstract][Full Text] [Related]
16. MiRNA203 suppresses the expression of protumorigenic STAT1 in glioblastoma to inhibit tumorigenesis.
Yang CH; Wang Y; Sims M; Cai C; He P; Yue J; Cheng J; Boop FA; Pfeffer SR; Pfeffer LM
Oncotarget; 2016 Dec; 7(51):84017-84029. PubMed ID: 27705947
[TBL] [Abstract][Full Text] [Related]
17. Effect of genetic variation in microRNA binding site in WNT1-inducible signaling pathway protein 1 gene on oral squamous cell carcinoma susceptibility.
Lau HK; Wu ER; Chen MK; Hsieh MJ; Yang SF; Wang LY; Chou YE
PLoS One; 2017; 12(4):e0176246. PubMed ID: 28426731
[TBL] [Abstract][Full Text] [Related]
18. High expression of WISP1 promotes metastasis and predicts poor prognosis in hepatocellular carcinoma.
Wang QY; Feng YJ; Ji R
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10445-10451. PubMed ID: 33155200
[TBL] [Abstract][Full Text] [Related]
19. Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors.
Wang Z; Yang J; Xu G; Wang W; Liu C; Yang H; Yu Z; Lei Q; Xiao L; Xiong J; Zeng L; Xiang J; Ma J; Li G; Wu M
Oncotarget; 2015 Feb; 6(5):3147-64. PubMed ID: 25605243
[TBL] [Abstract][Full Text] [Related]
20. WISP1 mediates IL-6-dependent proliferation in primary human lung fibroblasts.
Klee S; Lehmann M; Wagner DE; Baarsma HA; Königshoff M
Sci Rep; 2016 Feb; 6():20547. PubMed ID: 26867691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
